相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Review on Benzimidazole Scaffolds as Inhibitors of Mycobacterium tuberculosis Mycolyl-arabinogalactan-peptidoglycan Complex Biosynthesis
Vaishnav Bhaskar et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2023)
Novel 4-aminoquinolines: Synthesis, inhibition of the Mycobacterium tuberculosis enoyl-acyl carrier protein reductase, antitubercular activity, SAR, and preclinical evaluation
Josiane Delgado Paz et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)
Development of Isopropyl-Tailed Chalcones as a New Class of Selective MAO-B Inhibitors for the Treatment of Parkinson?s Disorder
Sunil Kumar et al.
ACS OMEGA (2023)
Design, synthesis and molecular docking studies of imidazole and benzimidazole linked ethionamide derivatives as inhibitors of InhA and antituberculosis agents
M. S. Raghu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2022)
Linking azoles to isoniazid via hydrazone bridge: Synthesis, crystal structure determination, antitubercular evaluation and computational studies
Ebru Kocak Aslan et al.
JOURNAL OF MOLECULAR LIQUIDS (2022)
Design, synthesis and anti-Mycobacterium tuberculosis evaluation of new thiazolidin-4-one and thiazolo[3,2-a][1,3,5]triazine derivatives
Mohamed H. Younis et al.
BIOORGANIC CHEMISTRY (2022)
Network analysis and ligand-based pharmacophore modeling for discovery of small molecule against glioblastoma multiforme
Vishnu Vasanthi Radhakrishnan et al.
FUTURE MEDICINAL CHEMISTRY (2022)
Synthesis, Molecular Modeling Study, and Quantum-Chemical-Based Investigations of Isoindoline-1,3-diones as Antimycobacterial Agents
Iqrar Ahmad et al.
ACS OMEGA (2022)
Design, Synthesis and Molecular Docking of Novel Acetophenone-1,2,3-Triazoles Containing Compounds as Potent Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors
Fawzia Faleh Albelwi et al.
PHARMACEUTICALS (2022)
Novel diaryl ether derivatives as InhA inhibitors: Design, synthesis and antimycobacterial activity
Ola A. Abdelaziz et al.
BIOORGANIC CHEMISTRY (2022)
Identification of hydantoin based Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) inhibitors as antimycobacterial agents using computational tools
Suraj N. Mali et al.
SCIENTIFIC REPORTS (2022)
Balanced QSAR and Molecular Modeling to Identify Structural Requirements of Imidazopyridine Analogues as Anti-infective Agents Against Trypanosomiases
Suraj N. Mali et al.
JOURNAL OF COMPUTATIONAL BIOPHYSICS AND CHEMISTRY (2022)
Synthesis, In silico and In vitro Analysis of Hydrazones as Potential Antituberculosis Agents
Bapu R. Thorat et al.
CURRENT COMPUTER-AIDED DRUG DESIGN (2021)
Mycobacterium enoyl acyl carrier protein reductase (InhA): A key target for antitubercular drug discovery
Mayuri S. Prasad et al.
BIOORGANIC CHEMISTRY (2021)
Design and antiproliferative and antioxidant activities of furan-based thiosemicarbazides and 1,2,4-triazoles: their structure-activity relationship and SwissADME predictions
Yusuf Sicak
MEDICINAL CHEMISTRY RESEARCH (2021)
Molecular Modeling Studies on 2,4-Disubstituted Imidazopyridines as Anti-Malarials: Atom-Based 3D-QSAR, Molecular Docking, Virtual Screening, In-Silico ADMET and Theoretical Analysis
Suraj N. Mali et al.
JOURNAL OF COMPUTATIONAL BIOPHYSICS AND CHEMISTRY (2021)
Computational characterization of epitopic region within the outer membrane protein candidate in Flavobacterium columnare for vaccine development
Manojit Bhattacharya et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
First triclosan-based macrocyclic inhibitors of InhA enzyme
Frederic Rodriguez et al.
BIOORGANIC CHEMISTRY (2020)
Molecular dynamics simulation exploration of the interaction between curcumin and myosin combined with the results of spectroscopy techniques
Li Zhang et al.
FOOD HYDROCOLLOIDS (2020)
Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors
Mohamad Sabbah et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
MmpL3 inhibitors as antituberculosis drugs
Min Shao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discovery of novel N-methyl carbazole tethered rhodanine derivatives as direct inhibitors of Mycobacterium tuberculosis InhA
Mahamadhanif S. Shaikh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
New isoniazid derivatives with improved pharmaco-toxicological profile: Obtaining, characterization and biological evaluation
Ionut Dragostin et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Chemical synthesis, molecular modeling and pharmacophore mapping of new pyrrole derivatives as inhibitors of InhA enzyme and Mycobacterium tuberculosis growth
Shrinivas D. Joshi et al.
MEDICINAL CHEMISTRY RESEARCH (2019)
New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action
Rudolf Vosatka et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
New hydrazides derivatives of isoniazid against Mycobacterium tuberculosis: Higher potency and lower hepatocytotoxicity
Frederico Silva Castelo-Branco et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
An overview on crystal structures of InhA protein: Apo-form, in complex with its natural ligands and inhibitors
Aurelien Chollet et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Novel compounds targeting InhA for TB therapy
Manaf AlMatara et al.
PHARMACOLOGICAL REPORTS (2018)
Pharmacophore mapping, molecular docking, chemical synthesis of some novel pyrrolyl benzamide derivatives and evaluation of their inhibitory activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis
Shrinivas D. Joshi et al.
BIOORGANIC CHEMISTRY (2018)
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
Nafees Ahmad et al.
LANCET (2018)
Discovery of a cofactor-independent inhibitor of Mycobacterium tuberculosis InhA
Yi Xia et al.
LIFE SCIENCE ALLIANCE (2018)
Epigallocatechin Gallate, a Green Tea Polyphenol Inhibits Mycobacterium smegmatis: In silico and In vitro Studies
S. Narayanan et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
New drugs for the treatment of Mycobacterium tuberculosis infection
Manaf AlMatar et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Direct inhibitors of InhA are active against Mycobacterium tuberculosis
Ujjini H. Manjunatha et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
In Silico Comparison of Low- and High-Risk Human Papillomavirus Proteins
Mahsa Alemi et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2014)
Encoded Library Technology as a Source of Hits for the Discovery and Lead Optimization of a Potent and Selective Class of Bactericidal Direct Inhibitors of Mycobacterium tuberculosis InhA
Lourdes Encinas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Pyridomycin bridges the NADH- and substratebinding pockets of the enoyl reductase InhA
Ruben C. Hartkoorn et al.
NATURE CHEMICAL BIOLOGY (2014)
Targeting InhA, the FASII Enoyl-ACP Reductase: SAR Studies on Novel Inhibitor Scaffolds
Pan Pan et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins
Markus Wiederstein et al.
NUCLEIC ACIDS RESEARCH (2007)
PHASE: A novel approach to pharmacophore modeling and 3D database searching
Steven L. Dixon et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2006)
Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis
SV Ramaswamy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Multiobjective optimization in quantitative structure-activity relationships: Deriving accurate and interpretable QSARs
O Nicolotti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
分享论文
